Two Sigma Advisers’s BioSpecifics Technologies Corp. BSTC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-8,000
| Closed | -$423K | – | 2684 |
|
|
2020
Q3 | $423K | Sell |
8,000
-2,300
| -22% | -$142K | ﹤0.01% | 1884 |
|
|
2020
Q2 | $631K | Sell |
10,300
-2,000
| -16% | -$116K | ﹤0.01% | 1784 |
|
|
2020
Q1 | $696K | Sell |
12,300
-400
| -3% | -$22.8K | ﹤0.01% | 1653 |
|
|
2019
Q4 | $723K | Buy |
12,700
+5,000
| +65% | +$265K | ﹤0.01% | 1714 |
|
|
2019
Q3 | $412K | Sell |
7,700
-1,400
| -15% | -$81.5K | ﹤0.01% | 1789 |
|
|
2019
Q2 | $543K | Buy |
9,100
+900
| +11% | +$56.6K | ﹤0.01% | 1777 |
|
|
2019
Q1 | $511K | Sell |
8,200
-4,100
| -33% | -$271K | ﹤0.01% | 1792 |
|
|
2018
Q4 | $745K | Sell |
12,300
-1,700
| -12% | -$102K | ﹤0.01% | 1617 |
|
|
2018
Q3 | $819K | Buy |
14,000
+1,100
| +9% | +$56.1K | ﹤0.01% | 1582 |
|
|
2018
Q2 | $579K | Sell |
12,900
-2,500
| -16% | -$108K | ﹤0.01% | 1866 |
|
|
2018
Q1 | $683K | Hold |
15,400
| – | – | ﹤0.01% | 1704 |
|
|
2017
Q4 | $667K | Sell |
15,400
-600
| -4% | -$27K | ﹤0.01% | 1677 |
|
|
2017
Q3 | $744K | Sell |
16,000
-1,900
| -11% | -$91K | ﹤0.01% | 1595 |
|
|
2017
Q2 | $886K | Hold |
17,900
| – | – | ﹤0.01% | 1577 |
|
|
2017
Q1 | $981K | Sell |
17,900
-4,200
| -19% | -$222K | ﹤0.01% | 1587 |
|
|
2016
Q4 | $1.23M | Sell |
22,100
-400
| -2% | -$19.2K | ﹤0.01% | 1459 |
|
|
2016
Q3 | $1.03M | Sell |
22,500
-3,800
| -14% | -$153K | ﹤0.01% | 1336 |
|
|
2016
Q2 | $1.05M | Sell |
26,300
-3,400
| -11% | -$125K | 0.01% | 1140 |
|
|
2016
Q1 | $1.03M | Buy |
29,700
+5,500
| +23% | +$202K | 0.01% | 1102 |
|
|
2015
Q4 | $1.04M | Sell |
24,200
-300
| -1% | -$15K | 0.01% | 1003 |
|
|
2015
Q3 | $1.07M | Buy |
24,500
+500
| +2% | +$27K | 0.01% | 984 |
|
|
2015
Q2 | $1.24M | Buy |
24,000
+3,600
| +18% | +$153K | 0.01% | 1029 |
|
|
2015
Q1 | $799K | Sell |
20,400
-2,500
| -11% | -$98K | 0.01% | 1165 |
|
|
2014
Q4 | $884K | Buy |
22,900
+15,600
| +214% | +$595K | 0.01% | 1237 |
|
|
2014
Q3 | $258K | Buy |
+7,300
| New | +$214K | ﹤0.01% | 1983 |
|
Other funds holding BSTC
Two Sigma Advisers's BSTC Position: Q4 2020 in Review
Two Sigma Advisers sold out of BioSpecifics Technologies Corp. (BSTC) in Q4 2020, closing a stake of 8,000 shares — an estimated $423K sold.
Two Sigma Advisers first reported a position in BSTC in Q3 2014 and held it in 25 quarters. The position peaked at $1.24M in Q2 2015. 1 fund tracked by Wall St. Rank holds BSTC as of Q4 2020.
- Two Sigma Advisers reported no remaining BioSpecifics Technologies Corp. position as of Q4 2020 after selling out during the quarter.
- Two Sigma Advisers sold 8,000 BioSpecifics Technologies Corp. shares in Q4 2020, an estimated $423K.
- Two Sigma Advisers first reported a position in BioSpecifics Technologies Corp. in Q3 2014 and held it in 25 quarters.
- Two Sigma Advisers's BioSpecifics Technologies Corp. position peaked at $1.24M in Q2 2015.
- 1 fund tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q4 2020.
Based on Two Sigma Advisers's 13F filing for Q4 2020, filed 16 Feb 2021.